These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8152528)

  • 1. Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats.
    Baumann MH; Rutter JJ; Auerbach SB
    Neuropharmacology; 1993 Dec; 32(12):1381-6. PubMed ID: 8152528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain.
    Baumann MH; Ayestas MA; Dersch CM; Rothman RB
    Neuropsychopharmacology; 2001 May; 24(5):492-501. PubMed ID: 11282249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted piperazine and indole compounds increase extracellular serotonin in rat diencephalon as determined by in vivo microdialysis.
    Auerbach SB; Rutter JJ; Juliano PJ
    Neuropharmacology; 1991 Apr; 30(4):307-11. PubMed ID: 1852265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain.
    Eriksson E; Engberg G; Bing O; Nissbrandt H
    Neuropsychopharmacology; 1999 Mar; 20(3):287-96. PubMed ID: 10063489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation.
    Rutter JJ; Gundlah C; Auerbach SB
    Synapse; 1995 Jul; 20(3):225-33. PubMed ID: 7570354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT(2C/2B) receptor agonist, m-chlorophenylpiperazine, increases plasma glucagon levels in rats.
    Yamada J; Sugimoto Y
    Eur J Pharmacol; 2000 Oct; 406(1):153-7. PubMed ID: 11011047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.
    Kontis D; Boulougouris V; Papakosta VM; Kalogerakou S; Papadopoulos S; Poulopoulou C; Papadimitriou GN; Tsaltas E
    Psychopharmacology (Berl); 2008 Nov; 200(4):597-610. PubMed ID: 18622751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain.
    Baumann MH; Mash DC; Staley JK
    Neuroreport; 1995 Nov; 6(16):2150-2. PubMed ID: 8595191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity.
    Baumann MH; Ayestas MA; Dersch CM; Partilla JS; Rothman RB
    Ann N Y Acad Sci; 2000 Sep; 914():172-86. PubMed ID: 11085319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a long-term low tryptophan diet on the prolactin responses to the 5-HT1A and 5-HT2C agonists, 8-OH-DPAT and mCPP in the male rat.
    Franklin M; Craven RD; Dowling B; Campling G; Elliott JM; Cowen PJ
    J Psychopharmacol; 1999; 13(1):58-63. PubMed ID: 10221360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men.
    Meltzer HY; Maes M
    Psychiatry Res; 1995 Sep; 58(2):89-98. PubMed ID: 8570772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine.
    Rutter JJ; Gundlah C; Auerbach SB
    Neurosci Lett; 1994 Apr; 171(1-2):183-6. PubMed ID: 8084487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin receptors in the caudal brainstem are necessary and sufficient for the anorectic effect of peripherally administered mCPP.
    Kaplan JM; Song S; Grill HJ
    Psychopharmacology (Berl); 1998 May; 137(1):43-9. PubMed ID: 9631955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute uptake inhibition increases extracellular serotonin in the rat forebrain.
    Rutter JJ; Auerbach SB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1319-24. PubMed ID: 7685386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cortical reorganization on the effect of 5-HT pharmacotherapy for spinal cord injury.
    Moxon KA; Kao T; Shumsky JS
    Exp Neurol; 2013 Feb; 240():17-27. PubMed ID: 23159333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of meta-chlorophenylpiperazine-induced inhibition of exploratory activity in an emergence procedure, the open field test, in rats.
    Meert TF; Melis W; Aerts N; Clincke G
    Behav Pharmacol; 1997 Aug; 8(4):353-63. PubMed ID: 9832994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin-releasing effects of substituted piperazines in vitro.
    Pettibone DJ; Williams M
    Biochem Pharmacol; 1984 May; 33(9):1531-5. PubMed ID: 6610423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic chlorophenylpiperazine increases acetylcholine release from rat hippocampus-implication of 5-HT2C receptors.
    Zhelyazkova-Savova M; Giovannini MG; Pepeu G
    Pharmacol Res; 1999 Aug; 40(2):165-70. PubMed ID: 10433876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.